Targeting Neurons Involved in Chronic Pain Transmission
Targeting Neurons Involved in Chronic Pain Transmission
批准号:
6344012
负责人:
Douglas A Lappi
金额:
$13.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-20 至 2002-09-30
关键词:
biological signal transduction biomaterial development /preparation chemical conjugate chronic pain complementary DNA dorsal horn embryo /fetus tissue /cell culture green fluorescent proteins laboratory rat neural transmission neurons neuropeptide receptor plasmids polylysine receptor expression spinal cord substance P transposon /insertion element
中文摘要
描述(摘自申请者的摘要):慢性疼痛是一种巨大的
美国的问题:估计有3000万到1亿人
受苦受罪。通常,目前的治疗方法是无效的,而且
患者经常被描述为“服务不足”。根据最近的数据,
慢性疼痛通过P物质受体表达的神经元传递
脊髓的后角。这些神经元的消除终止于
慢性疼痛信号在几种大鼠模型中的传递。不过,这个
方法依赖于脊髓神经元的死亡。另一种方法是
维持神经系统的完整性只会破坏
这些神经元的活动。这可以通过内部化来实现
分子进入P物质受体表达神经元,干扰
传递慢性疼痛信号的能力。在此阶段I中提出了
应用程序演示了一种表达系统,用于表达
可以导致这种破坏的分子可以内化到P物质中
受体表达神经元,能表达一种标志性蛋白-绿色荧光
蛋白。这一申请的成功可能会导致解决
干扰慢性疼痛治疗的严重问题。
建议的商业应用:
这一提议将导致开发一种表达系统,用于在内部操纵细胞以扰乱或改变其功能。这样的系统将在科学研究中有很多应用,不仅在慢性疼痛方面,而且在科学家试图改变细胞过程的任何领域都有应用。此外,一种可以减弱而不是破坏细胞功能的表达系统在疾病治疗中将有很大的可能性。
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous
problem in the United States: it is estimated that 30 to 100 million people
suffer from it. Often, current treatments are ineffective and the population of
sufferers is often described as "under-served." According to recent data,
chronic pain is transmitted through the Substance P receptor-expressing neurons
of the dorsal horn of the spinal cord. Elimination of these neurons terminates
transmission of the chronic pain signal in several rat models. However, this
method relied on the death of spinal cord neurons. An alternative method that
would maintain the integrity of the neuronal system would be to only disrupt
the activities of these neurons. This could be achieved by internalizing
molecules into Substance P receptor-expressing neurons that interfere with the
ability to transmit the chronic pain signal. It is proposed in this Phase I
application to demonstrate that an expression system, useful for expressing
molecules that can cause this disruption, can be internalized into Substance P
receptor-expressing neurons and can express a marker protein, green fluorescent
protein. The success of this application could result in the resolution of
serious problems that interfere with the treatment of chronic pain.
PROPOSED COMMERCIAL APPLICATION:
This proposal will result in the development of an expression system for use in internally manipulating cells to disrupt or alter their function. Such a system would have many applications in scientific research, not only in chronic pain, but in any area where scientists seek to alter cell processes. Additionally, an expression system that can diminish rather than destroy a cell's function would have great possibility in the treatment of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing CRISPR-based Therapeutic Interventions Via a Targeted Platform Tool
-
批准号:9253170
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2017
-
负责人:Douglas A Lappi
-
依托单位:
Development of a Novel Cancer Pain Therapeutic
-
批准号:7928286
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2010
-
负责人:Douglas A Lappi
-
依托单位:
Targeting a Poor Prognosis Marker for Tumor Therapy
-
批准号:7999984
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2010
-
负责人:Douglas A Lappi
-
依托单位:
Selective Activation in Specific Neuronal Populations
-
批准号:7538504
-
项目类别:
-
资助金额:$9.92万
-
财政年份:2009
-
负责人:Douglas A Lappi
-
依托单位:
Inhibition of Neurotransmission in Specific Neuronal Populations
-
批准号:7482543
-
项目类别:
-
资助金额:$11.43万
-
财政年份:2008
-
负责人:Douglas A Lappi
-
依托单位:
Isolation of Pancreatic Islets by FACS
-
批准号:6443679
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:Douglas A Lappi
-
依托单位:
A TOOL TO STUDY THE DIVERSE BEHAVIOR EFFECTS OF GALANIN
-
批准号:6210155
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2000
-
负责人:Douglas A Lappi
-
依托单位:
MAB'S TO TARGET SPECIFIC NEURONAL POPULATIONS
-
批准号:2873100
-
项目类别:
-
资助金额:$11.32万
-
财政年份:1999
-
负责人:Douglas A Lappi
-
依托单位:
TOOLS FOR THE DISSECTION OF PAIN TRANSMISSION PATHWAYS
-
批准号:6022028
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:Douglas A Lappi
-
依托单位:
Monoclonal Antibodies to Target Neuronal Populations
-
批准号:6585715
-
项目类别:
-
资助金额:$34.13万
-
财政年份:1999
-
负责人:Douglas A Lappi
-
依托单位:
Monoclonal Antibodies to Target Neuronal Populations
-
批准号:6851809
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1999
-
负责人:Douglas A Lappi
-
依托单位:
Monoclonal Antibodies to Target Neuronal Populations
-
批准号:6698825
-
项目类别:
-
资助金额:$28.22万
-
财政年份:1999
-
负责人:Douglas A Lappi
-
依托单位:
NEW TOOLS FOR BASIC NEUROBIOLOGICAL RESEARCH
-
批准号:6550417
-
项目类别:
-
资助金额:$27.61万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
Drug Development of a Chronic Pain Therapeutic
-
批准号:6692707
-
项目类别:
-
资助金额:$79.97万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
Drug Development of a Chronic Pain Therapeutic
-
批准号:6919960
-
项目类别:
-
资助金额:$78.92万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
Drug Development of a Chronic Pain Therapeutic
-
批准号:6803957
-
项目类别:
-
资助金额:$80.0万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
NEW TOOL FOR BASIC NEUROBIOLOGICAL RESEARCH
-
批准号:2035047
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
NEW TOOLS FOR BASIC NEUROBIOLOGICAL RESEARCH
-
批准号:2650727
-
项目类别:
-
资助金额:$40.46万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
TOXICOLOGY/SAFETY STUDIES OF A CHRONIC PAIN THERAPEUTIC
-
批准号:6292613
-
项目类别:
-
资助金额:$39.8万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位:
NEW TOOLS FOR BASIC NEUROBIOLOGICAL RESEARCH
-
批准号:2890877
-
项目类别:
-
资助金额:$34.48万
-
财政年份:1996
-
负责人:Douglas A Lappi
-
依托单位: